Advanced search
Publication Cover
Clinical Epidemiology Volume 12, 2020 - Issue
Submit an article Journal homepage
290
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis

Katrina Wilcox Hagberg1 Boston Collaborative Drug Surveillance Program, Lexington, MA02421, USAORCID Iconhttps://orcid.org/0000-0002-2407-2995
ORCID Icon,
Rebecca Persson1 Boston Collaborative Drug Surveillance Program, Lexington, MA02421, USA
,
Catherine Vasilakis-Scaramozza1 Boston Collaborative Drug Surveillance Program, Lexington, MA02421, USA
,
Steve Niemcryk2 Celgene Corporation, Summit, NJ07901, USA
,
Michael Peng2 Celgene Corporation, Summit, NJ07901, USA
,
Maria Paris2 Celgene Corporation, Summit, NJ07901, USA
,
Anders Lindholm2 Celgene Corporation, Summit, NJ07901, USA
&
Susan Jick1 Boston Collaborative Drug Surveillance Program, Lexington, MA02421, USA;3 Boston University School of Public Health, Lexington, MA02421, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2215-1067
ORCID Icon show all
Pages 153-161 | Published online: 12 Feb 2020

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jia C Gao, Albert G Wu, Marissa N Contento, Jacqueline M Maher & Abigail Cline. (2022) Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis. Clinical, Cosmetic and Investigational Dermatology 15, pages 395-402.
Read now
Clara De Simone, Maria Concetta Fargnoli, Paolo Amerio, Luca Bianchi, Maria Esposito, Federico Pirro, Concetta Potenza, Federica Ricceri, Franco Rongioletti, Luca Stingeni & Francesca Prignano. (2021) Risk of infections in psoriasis: assessment and challenges in daily management. Expert Review of Clinical Immunology 17:11, pages 1211-1220.
Read now

Articles from other publishers (12)

Shingo Konno, Takafumi Uchi, Jun Isonishi, Mari Matsushima, Hideo Kihara, Hideki Sugimoto & Toshiki Fujioka. (2022) Development of infections among patients with myasthenia gravis undergoing immunotherapy. Clinical and Experimental Neuroimmunology 14:1, pages 34-43.
Crossref
Katarzyna Korecka, Anna Wiśniewska‐Szymańska & Dominik Mikiel. (2022) The impact of systemic psoriasis treatments on human papillomavirus activation and propagation. Australasian Journal of Dermatology 63:3, pages 293-302.
Crossref
Alfonso Motolese, Manuela Ceccarelli, Laura Macca, Federica Li Pomi, Ylenia Ingrasciotta, Giuseppe Nunnari & Claudio Guarneri. (2022) Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease. Biomedicines 10:2, pages 228.
Crossref
Hsien-Yi Chiu, Yi-Teng Hung, Shi-Wei Huang & Yu-Huei Huang. (2022) Comparative risk of herpes zoster in patients with psoriatic disease on systemic treatments: a systematic review and network meta-analysis. Therapeutic Advances in Chronic Disease 13, pages 204062232210911.
Crossref
Matheus Vieira, Mathieu Vautier, Frédéric Charlotte & David Saadoun. (2021) Mycobacterium bovis infection under apremilast in Behçet's syndrome . Rheumatology 60:9, pages e301-e303.
Crossref
M. M. Baranova, N. V. Muravyeva & B. S. Belov. (2021) The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data). Meditsinskiy sovet = Medical Council:2, pages 122-126.
Crossref
Andrea Picchianti-Diamanti, Francesca Romana Spinelli, Maria Manuela Rosado, Fabrizio Conti & Bruno Laganà. (2021) Inhibition of Phosphodiesterase-4 in Psoriatic Arthritis and Inflammatory Bowel Diseases. International Journal of Molecular Sciences 22:5, pages 2638.
Crossref
Matheus Vieira, Solène Buffier, Mathieu Vautier, Alexandre Le Joncour, Yvan Jamilloux, Mathieu Gerfaud-Valentin, Laurence Bouillet, Estibaliz Lazaro, Stéphane Barete, Laurent Misery, Delphine Gobert, Tiphaine Goulenok, Olivier Fain, Karim Sacre, Pascal Sève, Patrice Cacoub, Cloé Comarmond & David Saadoun. (2021) Apremilast in Refractory Behçet’s Syndrome: A Multicenter Observational Study. Frontiers in Immunology 11.
Crossref
Olivier Lortholary, Mario Fernandez-Ruiz, John W Baddley, Oriol Manuel, Xavier Mariette & Kevin L Winthrop. (2020) Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020. Annals of the Rheumatic Diseases 79:12, pages 1532-1543.
Crossref
N. V. Muravyeva, B. S. Belov, M. M. Baranova & T. V. Korotaeva. (2020) Comorbid infections in spondyloarthritis: a modern view of the problem. Modern Rheumatology Journal 14:4, pages 103-110.
Crossref
B. S. Belov, N. V. Muravyova, M. M. Baranova & T. V. Korotaeva. (2020) Problem of comorbid infections in patients with psoriatic arthritis. Medical alphabet:15 (2020), pages 22-28.
Crossref
Susana Armesto, Carmen González Vela & Marco Antonio González López. (2020) Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID‐19 era. Dermatologic Therapy 33:4.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.